Ulf Landmesser

[Impact of lipid metabolism parameters on the development and progression of coronary artery disease : An update].

[Catheter-based closure of the left atrial appendage : Stroke prevention in atrial fibrillation].

[ECS guidelines 2016 - dyslipidaemias].

MicroRNAs in lipid metabolism and atherosclerosis.

Loop Recorder Detected High Rate of Atrial Fibrillation Recurrence after a Single Balloon- or Basket-Based Ablation of Paroxysmal Atrial Fibrillation: Results of the MACPAF Study.

The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis.

[Dyslipidemias : Diagnostics and management].

[Recent and upcoming randomized trials for left atrial appendage occlusion : Need for a definite assessment of the situation].

Dual antiplatelet therapy after percutaneous coronary intervention for stable CAD or ACS : Redefining the optimal duration of treatment.

[Catheter-based atrial appendage closure-current data and future developments].

Is There a Need to Revise Goals in the Management of Dyslipidemias?

[Left atrial appendage closure for stroke prevention in atrial fibrillation : An update].

Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran).

Digital technology to support self-management in patients with coronary disease.

Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19.